Fellowship · Saint Louis, MO
Sponsored by SSM Health/Saint Louis University School of Medicine
Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR.
Transplantation and cellular therapy · 2025 · 87 citations · Amy Moskop
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 212 citations · Amy Moskop
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry.
Transplantation and cellular therapy · 2024 · 76 citations · Amy Moskop
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 58 citations · William Ferguson
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Transplantation and cellular therapy · 2023 · 68 citations · Amy Moskop
Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy.
Blood advances · 2022 · 108 citations · Amy Moskop
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes.
Transplantation and cellular therapy · 2022 · 79 citations · Amy Moskop
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
Blood advances · 2024 · 31 citations · Deepika Bhatla